We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CME Group (CME) Q1 Earnings Top Estimates, Revenues Miss
Read MoreHide Full Article
Have you been eager to see how CME Group Inc. (CME - Free Report) , one of the largest futures exchanges in the world, performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this Chicago, IL-based company’s earnings release this morning.
An Earnings Beat
CME Group reported adjusted earnings per share of $1.86, beating the Zacks Consensus Estimate of $1.85.
You should note that the earnings estimate for CME Group depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $1.85 per share over the last 7 days.
Also, CME Group has a solid earnings surprise history.
Overall, the company surpassed the Zacks Consensus Estimate by an average of nearly 1.86% in the trailing four quarters.
Revenues Came in Lower Than Expected
CME Group’s revenues of $1.11 billion improved 19.3% year over year. However, the reported missed the Zacks Consensus Estimate of $1.12 billion.
Key Takeaways
Average daily volume (ADV) increased nearly 30% year over year to an all-time high of 22.2 million contracts, due to higher volumes across all the six product lines.
Total expenses increased 12.1% year over year at $368.1 million during the reported quarter.
Operating income improved 23.3% to $740.9 million from the prior-year quarter.
As of Mar 31, 2018, long-term debt of $2.2 billion remained flat with the level at year-end 2017.
What Zacks Rank Says
The estimate revisions that we discussed earlier have driven a Zacks Rank #2 (Buy) for CME Group. However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. Now it all depends on what sense the just-released report makes to the analysts.
Check back later for our full write up on this CME Group earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
CME Group (CME) Q1 Earnings Top Estimates, Revenues Miss
Have you been eager to see how CME Group Inc. (CME - Free Report) , one of the largest futures exchanges in the world, performed in Q1 in comparison with the market expectations? Let’s quickly scan through the key facts from this Chicago, IL-based company’s earnings release this morning.
An Earnings Beat
CME Group reported adjusted earnings per share of $1.86, beating the Zacks Consensus Estimate of $1.85.
CME Group Inc. Price and EPS Surprise
CME Group Inc. Price and EPS Surprise | CME Group Inc. Quote
How Was the Estimate Revision Trend?
You should note that the earnings estimate for CME Group depicted neutral stance prior to the earnings release. The Zacks Consensus Estimate remained unchanged at $1.85 per share over the last 7 days.
Also, CME Group has a solid earnings surprise history.
Overall, the company surpassed the Zacks Consensus Estimate by an average of nearly 1.86% in the trailing four quarters.
Revenues Came in Lower Than Expected
CME Group’s revenues of $1.11 billion improved 19.3% year over year. However, the reported missed the Zacks Consensus Estimate of $1.12 billion.
Key Takeaways
Average daily volume (ADV) increased nearly 30% year over year to an all-time high of 22.2 million contracts, due to higher volumes across all the six product lines.
Total expenses increased 12.1% year over year at $368.1 million during the reported quarter.
Operating income improved 23.3% to $740.9 million from the prior-year quarter.
As of Mar 31, 2018, long-term debt of $2.2 billion remained flat with the level at year-end 2017.
What Zacks Rank Says
The estimate revisions that we discussed earlier have driven a Zacks Rank #2 (Buy) for CME Group. However, since the latest earnings performance is yet to be reflected in the estimate revisions, the rank is subject to change. Now it all depends on what sense the just-released report makes to the analysts.
You can see the complete list of today’s Zacks #1Rank (Strong Buy) stocks here.
Check back later for our full write up on this CME Group earnings report!
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>